<DOC>
	<DOCNO>NCT01893606</DOCNO>
	<brief_summary>This study withdrawal randomize clinical trail evaluate clinical efficacy safety 1.1 chemical drug N-acetyl glucosamine Chinese IBS-D patient come four center chongqing . 180 IBS-D patient research accord Rome III diagnostic criterion , screening/import period pain intensity score NRS week mean value 3.0 plus day least one time stool type 6 7 type 2 days/week . Test cycle include screening/import period ( 2 week ) , open treatment period ( 8 week ) , double-blind placebo-controlled randomize withdrawal period ( 8 week ) , main outcome measure pain intensity ( NRS score 11 point scale ) stool type ( Bristol type ) . And secondary endpoint include overall symptom sensory score , defecation frequency , abdominal distension , mucous stool quality life parameter ( IBS-36 scale ) . After end treatment period , participant whose pain intensity stool type effective subject randomize withdrawal period , analysis comparison difference treatment group placebo group withdrawal rate curative effect index score reduces .</brief_summary>
	<brief_title>Multicenter Withdrawal Clinical Trials N-acetyl Glucosamine Capsule IBS-D Treatment</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Man woman , age 18 65 year , inclusive . Based Roman III diagnostic criterion diagnosis IBSD subject , recurrent abdominal pain discomfort ( hard describe discomfort pain ) , monthly attack within past 3months least 3 day . With two follow three kind symptom : At least portion time abdominal pain defecate increase discomfort . At least portion time abdominal pain row loose stool discomfort . At least portion time abdominal pain discomfort improve defecation . Symptoms least 6 month diagnosis Screening/import period pain intensity score NRS week mean value 3.0 plus day least one time stool type 6 7 type 2 days/week . Voluntarily sign informed consent form The absorption know adverse History gastrointestinal surgery ( include appendectomy ) History organic gastrointestinal disease : IBS , cancer etc . History chronic disease : anemia ( hemoglobin &lt; 90g/L ) , pulmonary tuberculosis , diabetes cardiovascular , liver , kidney , brain , hematopoietic system serious disease psychiatric patient , AST ( aspartate aminotransferase ) , ALT ( alanine aminotransferase ) &gt; 1.5 time , BUN ( blood urea nitrogen ) &gt; 1.2 time , Cr &gt; 1.0 time normal . The disease lactose intolerance , gallstone , endometriosis , easily confuse IBS symptom ; Progressive weight loss ; Concomitant medication unable stop affect gastrointestinal movement function experiment , antibiotic drug , drug regulate intestinal microecology ; Concomitant medication use continuously week affect gastrointestinal movement function experiment , parasympathetic inhibitor , nondepolarizing agent , antidiarrheal , opioid formulation , etc ; Other researcher think suitable list ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>diarrhea</keyword>
	<keyword>abdominal pain</keyword>
</DOC>